Founder’s Factory Africa have announced their selection of RxAll a health startup that gives hospitals, pharmacies, and patients across Africa access to top-quality non-counterfeited medicines through an online process of verification.
RxAll is now in a good position to achieve its goal of transforming the Africa medication value chains through its Venture Scale programme. FFA is a venture development company working alongside Standard Bank Group and corporate investors Netcare Group.
As a B2B and B2C health platform RxAll joins the list of other health tech and fintech startups. FFA had earlier accepted 5 other startups into its program, notably, Bwala Africa from Kenya, Nigerian Agri-tech FoodLocker, and South African startups; booking platform LocumBase, biomedical startup AkiliLabs, and Envisionit Deep AI.
RxAll was founded by Adebayo Alonge (co-founder and CEO), Amy Kao (co-founder), and Wei Lui (co-founder).
RxAll links hospitals, pharmacies, and patients across Africa with top quality, non-counterfeit medicines online. The drugs are then authenticated and delivered from an organized pipeline. RxAll is also committed to providing high-quality medication to their patients through the RxScanner technology that can display the quality of the ingredients in a drug within seconds.
In the press release, Richard Friedland, CEO of Netcare Group shares, “RxAll is an exciting venture that allows patients to have better access to high quality medication and pharmacies to access authenticated medication.”
Roo Rogers, founder of FAA said, “Counterfeit medication is a global health crisis. Its effects can be seen across the global healthcare ecosystem with over 1 million people dying globally per year. RxAll offers a unique, simple, and precise solution with its RxScanner device. FFA is excited to support RxAll’s growth and impact by delivering investment, network, and growth with Adebayo Alonge and his team.”
You can submit your application to the Venture Scale program here as the window remains open-ended.